Herve Bhatt

Herve Bhatt develops industrial-scale organoid drug screening platforms at Novartis, integrating automated liquid handling, high-content imaging, and machine learning for efficient compound testing across patient-derived organoid panels. His work on organoid-on-chip microfluidic systems has enabled pharmacokinetically relevant drug exposure profiles that better predict clinical efficacy. He bridges academic organoid innovations with pharmaceutical drug development pipelines.